Bioqual, Inc. (BIOQ)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Mark G. Lewis Ph.D. | Chairman of the Board, CEO & President | -- | -- | 1955 |
| Mr. Charles C. Kirk Jr., CPA | Chief Financial Officer | -- | -- | -- |
| Mitch Franklin | Chief Operating Officer | -- | -- | -- |
| Dr. Hanne Andersen-Elyard Ph.D. | Chief Scientific Officer | -- | -- | -- |
Bioqual, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.
Corporate Governance
Upcoming Events
April 11, 2025 at 4:13 PM UTC
Bioqual, Inc. Earnings Date
Recent Events
October 28, 2024 at 12:00 AM UTC
Dividend Date
October 7, 2024 at 12:00 AM UTC
Ex-Dividend Date